Neurol. praxi. 2022;23(1):46-49 | DOI: 10.36290/neu.2021.085
Congenital myasthenic syndromes: rare, but treatable diseases
- 1 Oddělení dětské neurologie, Fakultní Thomayerova nemocnice, Praha
- 2 Centrum molekulární biologie a genetiky, Fakultní nemocnice Brno
Congenital myasthenic syndromes (CMS) are very rare and very variable. Recognition is not easy, but they are treatable diseases. Effect of treatment is variable, in some cases minimal, in some cases fundamentally changes the quality of life, it can mean the difference between life and death. Know-how and a single tube of blood for genetic testing could be sufficient for diagnosis. We present an overview of clinical symptoms, pathophysiology and classification of CMS types, diagnosis, differential diagnosis and treatment options.
Keywords: congenital myasthenic syndromes, neuromuscular junction, respiratory failure.
Received: September 13, 2021; Revised: September 27, 2021; Accepted: November 2, 2021; Prepublished online: November 2, 2021; Published: March 14, 2022 Show citation
References
- Adamovičová M, Fabríciová K, Jakubíková M, et al. Kongenitální myastenie jako příčina respiračního selhání u dvou kojenců a batolete - kazuistiky. Cesk Slov Neurol N. 2012;75/108(6): 757-762.
- Adamovičova M, Šišková D. Kongenitální myastenické syndromy - kazuistiky. Cesk Slov Neurol N. 2010;73/106(1):62-67.
- Engel AG. Genetic basis and phenotypic features of congenital myasthenic syndromes. Handb Clin Neurol. 2018; 148:565-589.
Go to original source... 
Go to PubMed... - Chae JH, Vasta V, Cho A, et al. Utility of next generation sequencing in genetic diagnosis of early onset neuromuscular disorders. J Med Genet. 2015;52(3):208-216. Go to original source... Go to PubMed...